BRISTOL, TN / ACCESS Newswire / March 9, 2026 / When Coeptis Therapeutics Holdings, Inc. (Nasdaq:COEP) and Z Squared Inc.

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides pharmacists, ...

The Company Has Established the Industry’s Most Advanced Portfolio of Clinical Trial Simulation Capabilities for ...

Built for the demands of modern imaging, View streamlines workflows, and helps enhance patient care as the advanced diagnostic viewer powering the Genesis Radiology WorkspaceCHICAGO--(BUSINESS ...

Announced at HIMSS26, the companies will deliver a bundled solution that unlocks advanced insights for study sponsorsDALLAS--(BUSINESS WIRE)--Verily Life Sciences and Samsung Electronics America today ...

UPPSALA, SE / ACCESS Newswire / March 9, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The Nomination Committee prior to the 2026 Annual General Meeting will consist of four ...

AnovoRx Holding, LLC (“Anovo”), a leading provider of specialty pharmacy services and customized treatment and support programs that address the unique needs of patients with complex and chronic ...

The Company Has Established the Industry’s Most Advanced Portfolio of Clinical Trial Simulation Capabilities for Pharmaceutical and Biotechnology CompaniesTEL AVIV, Israel--(BUSINESS ...

The Veterinary Software Market has experienced notable growth in recent years as veterinary clinics, hospitals, and research ...

Pittsburgh Corporation (NYSE: AP) (“Ampco-Pittsburgh”) today announced that its order activity in the first two months of 2026 increased 38% versus the same period last year. Both of ...

Overview of Medical Radiation Shielding MarketThe Medical Radiation Shielding Market plays a critical role in ensuring safety ...

Study marks the first positive Phase 3 study for mezigdomide and the second positive Phase 3 study for the Bristol Myers Squibb CELMoD programPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #CELMoD--Bristol ...